Cafepharma Today

April 25 2018 - Positive results for AbbVie’s rheumatoid med

Positive results for AbbVie’s rheumatoid med
Celldex laying off a quarter of its staff
GSK’s Trelegy Ellipta has new indication in US
Will Pfizer’s Trumenba catch up to GSK’s Besero?
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

Today's most popular searches:

For banking news and anonymous forums, be sure to check out cafebanking.com

Current News

submit a press release
Amgen focuses on migraine launch as growth remains slow
Biopharma Dive
Wednesday, April 25, 2018 - 10:54pm
tags:
Amgen, earnings, Repatha, Kyprolis, Prolia, Xgeva
Look at our new launches, GSK urges, as its respiratory woes steal the limelight
Fierce Pharma
Wednesday, April 25, 2018 - 10:38pm
tags:
GSK, earnings, HIV, Shingrix
Canadian STEMCELL Technologies Receives $45 Million Government Funding for Advanced Manufacturing Facility
CP Wire
Wednesday, April 25, 2018 - 10:32pm
tags:
STEMCELL Technologies, Canada, drug manufacturing
First Patient Dosed in Avexis' Phase 3 Trial of AVXS-101 in Pre-Symptomatic Spinal Muscular Atrophy
CP Wire
Wednesday, April 25, 2018 - 10:29pm
tags:
AveXis, Novartis, M&A, clinical trials, AVXS-101, gene therapy, spinal muscular atrophy
Biogen to increase stake in biosimilar developer Samsung Bioepis
Biopharma Dive
Wednesday, April 25, 2018 - 10:25pm
tags:
Biogen, biosimilars, Samsung Bioepis
Could Oral Biosimilars of Humira and Embrel Disrupt the Biologics Market?
Xtalks
Wednesday, April 25, 2018 - 10:23pm
tags:
biosimilars, Rani Therapeutics, Humira, Embrel
Is Vaxart One to Watch...Maybe?
CP Wire
Wednesday, April 25, 2018 - 2:40pm
tags:
Vaxart, vaccines, flu vaccine
OrphoMed's IBS-D Candidate ORP-101 Receives Fast Track Designation
CP Wire
Wednesday, April 25, 2018 - 1:09pm
tags:
OrphoMed, IBS-d, ORP-101, FDA, fast track
GSK boss rethinking R&D incentives, as Barron and Sin seek out early and late-stage ops
Fierce Biotech
Wednesday, April 25, 2018 - 1:07pm
tags:
GSK, R&D, Emma Walmsley
AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study
CP Wire
Wednesday, April 25, 2018 - 11:16am
tags:
AbbVie, rheumatoid arthritis, Upadacitinib, clinical trials

Pages

Latest CP Wire Articles

Eloxx Pharmaceuticals Seeks to Raise $50 Million in Public Offering
Catabasis Pharmaceuticals' Edasalonexent Slowed Duchenne Muscular Dystrophy Disease Progression Through One Year of Treatment
Canadian STEMCELL Technologies Receives $45 Million Government Funding for Advanced Manufacturing Facility
Is Vaxart One to Watch...Maybe?
First Patient Dosed in Avexis' Phase 3 Trial of AVXS-101 in Pre-Symptomatic Spinal Muscular Atrophy
OrphoMed's IBS-D Candidate ORP-101 Receives Fast Track Designation
AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study
New Data For Alder BioPharmaceuticals' Eptinezumab Shows Long-Term Reduction in Episodic Migraine
Mirati Therapeutics Announces Positive Results in Immuno-Oncology Combination Trials
Interview With Hatch-Waxman Expert Kurt Karst

Latest Pharmagather Articles

Medical Imaging and Pharma: Bridging the Gap
pharmexec technology
Calculate Your Way Out of Bad Yields
In the Pipeline
Are Online Social Networks the New Corporate Currency?
Digital Pharma Blog
The Fuzzy Free-For-All
In the Pipeline
The Gross-to-Net Bubble Topped $150 Billion in 2017
Drug Channels
BenevolentAI: Worth Two Billion?
In the Pipeline
CBI’s 14th Annual Commercial Contract & Chargeback Excellence
Drug Channels
FDA, Industry Prepare for New User Fee Initiatives
pharmexec r&d
Survival/Success in the Age of Too Much Information
pharmexec marketing
Pharma Jobs from Indeed

CP Wire

Submit an article to cafepharma's CP Wire. Click here to find out more.

Pharma and Device News from NASDAQ

NetworkNewsWire Announces Publication on Good News in Biotech Advancements Through Cannabis Delivery Technology
Wednesday, April 25, 2018 - 8:30am
Immune Design to Report First Quarter 2018 Financial Results and Provide Corporate Update
Wednesday, April 25, 2018 - 8:00am
Aptose Announces Appointment of Caroline M. Loewy to Board of Directors
Wednesday, April 25, 2018 - 7:00am
Sharps Compliance Reports Fiscal 2018 Third Quarter Results
Wednesday, April 25, 2018 - 6:55am
Sunniva Inc. to Delay Earnings Release Until April 30, 2018
Tuesday, April 24, 2018 - 9:39pm
Icon Media Holdings, Inc. Enters Into Joint Services Agreement with DMR Biologics
Tuesday, April 24, 2018 - 10:30am
Intrommune Therapeutics to Present at Eighth Annual BioNJ BioPartnering Conference
Tuesday, April 24, 2018 - 9:27am
Organovo to Present at 2nd Annual NASH Summit
Tuesday, April 24, 2018 - 8:05am
Catalyst Pharmaceuticals Introduces New Corporate Website
Tuesday, April 24, 2018 - 8:03am
Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018 Annual Cure SMA Conference
Tuesday, April 24, 2018 - 7:30am

Breaking Healthcare News - powered by Seeking Alpha

Premarket analyst action - healthcare
Tuesday, April 24, 2018 - 8:38am
Biogen Q1 revenues up 11%; non-GAAP EPS up 16%; shares off 1% premarket
Tuesday, April 24, 2018 - 8:10am
PAVmed in-licenses device used to detect precursor to esophageal cancer
Tuesday, April 24, 2018 - 8:08am
MEDNAX acquires Houston radiology practice
Tuesday, April 24, 2018 - 7:53am
Sanofi R&D chief to retire in late June
Tuesday, April 24, 2018 - 7:49am
TESARO's niraparib shows treatment effect in late-line ovarian cancer
Tuesday, April 24, 2018 - 7:38am
Eli Lilly Q1 revenues up 9%; non-GAAP EPS up 37%; raises 2018 guidance; shares ahead 3% premarket
Tuesday, April 24, 2018 - 7:24am
Prothena bails on AL amyloidosis candidate NEOD001; shares down 62% premarket
Monday, April 23, 2018 - 8:49am
ARCA Biopharma and Medtronic extend Gencaro clinical trial collaboration agreement
Monday, April 23, 2018 - 8:47am
Henry Schein to spin off and merge its animal health business with Vets First Choice
Monday, April 23, 2018 - 8:41am

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.